Can you trace the narcotics trail?

December 2011
Same-Day Surgery;Dec2011, Vol. 35 Issue 12, p128
Academic Journal
The article reports on a 2011 statement which Sheldon S. Sones, the president of the medication and pharmacy consulting firm Sheldon S. Sones and Associates, in which he indicated that drug diversion in health facilities can be avoided by addressing storage, documentation and quality assurance.


Related Articles

  • Achieving and sustaining ICD-10 success. BELLEY, SUSAN // Health Management Technology;Nov2015, Vol. 36 Issue 11, p18 

    The article discusses five areas that U.S. healthcare organizations should focus on to ensure compliance and success with the ICD-10 coding transition. It stresses the need for physicians to incorporate the new ICD-10 terminology and specificity into their documentation. It notes that the ICD-10...

  • The Value of ERROR REPORTS. Bassett, Mike // For the Record (Great Valley Publishing Company, Inc.);10/8/2012, Vol. 24 Issue 18, p10 

    The article discusses the accuracy rates in healthcare organization. It states that healthcare asked an effective coding compliance program to lessen the error rates that Health Information Management (HIM) experts considered the most significant. It mentions First Class Solutions Inc. cite two...

  • Implementing Quality Agreements at the Contract Laboratory. Wedlich, Richard C.; Webb, Kevin J // Journal of GXP Compliance;Autumn2012, Vol. 16 Issue 4, p54 

    The quality agreement (QAG) between a pharmaceutical company and its partnering contract research organization (CRO) is essential. This discussion outlines the elements of a useful quality agreement. It provides details of a simple procedure that the CRO can use to ensure that the terms of the...

  • Implementing an Effective GLP Program at the Contract Laboratory. Wedlich, Richard C.; Libera, Agata E.; Fransen, Joseph M.; Tellarini, C.; Heath, T.; Knight, N. // Journal of GXP Compliance;2015, Vol. 19 Issue 2, p1 

    This discussion provides an overview of a GLP program at a contract laboratory. The objective of the GLP program is generation of analytical data in support of a GLP study. Understanding what is required to complete a single study leads to understanding what quality systems must be in place in...

  • Case Studies: Connecting with the Compliance Community. Pluta, Paul L. // Journal of GXP Compliance;Spring2012, Vol. 16 Issue 2, p4 

    An introduction to the journal is presented in which the editor discusses some case studies published within the issue including one about defective secondary packages, substandard data and documentation practices and cleaning validation and unknown peaks in high-performance liquid...

  • Change Control for Functionally Equivalent Like-For-Like Changes. Pluta, Paul L. // Journal of GXP Compliance;Spring2012, Vol. 16 Issue 2, p34 

    Change control is a critical activity in regulated pharmaceutical manufacturing. Changes to manufacturing processes, formulations, equipment, cleaning procedures, analytical methods, and other systems are evaluated on risk or impact. Appropriate validation and qualification work is then...

  • Legal Climate: Compliance and Regulatory Risk Areas for Laboratories. Wood, Jane Pine; McGovern, Jenny // Clinical Leadership & Management Review;2013 Quater3, Vol. 27 Issue 3, p6 

    The article reviews the legal climate of the present laboratories, highlights special areas of concern and offers suggestions to reduce risk. Topics discussed include the major risk areas for laboratories such as missed diagnoses, specimen processing errors and technician errors in reading test...

  • Transcending Compliance. Porter, William R. // Journal of GXP Compliance;Aug2013, Vol. 17 Issue 3, p1 

    The article discusses the need to achieve superior quality by transcending compliance with current good pharmaceutical practices (cGxPs). According to the author, although achieving compliance is critical to success, it means just meeting minimum quality requirements. The author notes that...

  • A harmonized self-assessment tool for procurement agencies.  // WHO Drug Information;2014, Vol. 28 Issue 4, p434 

    In the absence of stringent regulatory systems for medicines in many parts of the world, procurement agencies have an important role in ensuring the quality of pharmaceutical products that they buy for use in treatment programmes. During the recent update of WHO’s quality assurance...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics